{
    "clinical_study": {
        "@rank": "37029", 
        "brief_summary": {
            "textblock": "PRIMARY: To determine the efficacy of azithromycin and rifabutin alone and in combination\n      for the prevention of disseminated Mycobacterium avium Complex (MAC) infection in\n      HIV-infected patients. To determine the efficacy of daily versus weekly fluconazole for the\n      prevention of deep fungal infections in this patient population.\n\n      SECONDARY: To determine the incidence of bacterial (including mycobacterial) infections,\n      cryptosporidiosis, and toxoplasmosis in azithromycin versus non-azithromycin containing\n      regimens. To determine the incidence of oropharyngeal and vaginal candidiasis in patients\n      treated with daily versus weekly fluconazole. To compare survival and outcomes of primary\n      endpoints in the treatment arms."
        }, 
        "brief_title": "A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients", 
        "condition": [
            "Mycoses", 
            "Mycobacterium Avium-Intracellulare Infection", 
            "HIV Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Mycobacterium Infections", 
                "Mycobacterium avium-intracellulare Infection", 
                "Mycoses"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients are randomized to receive azithromycin alone, rifabutin alone, or the two drugs in\n      combination for MAC prophylaxis. Patients in each treatment group further receive one of two\n      doses of concomitant fluconazole for deep fungal prophylaxis, unless specifically excluded\n      for fluconazole randomization. Patients are followed for 1 to 2 years."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Concurrent Medication:\n\n        Allowed:\n\n          -  Preventive therapy with isoniazid for M. tuberculosis.\n\n          -  Maintenance therapy for CMV retinitis.\n\n        Patients must have:\n\n          -  HIV infection or history of an AIDS-defining condition by CDC criteria.\n\n          -  One documented CD4 count < 100 cells/mm3 within 12 months prior to study entry.\n\n          -  NO active MAC disease, MAC bacteremia, or active  mycobacterial infection\n             (tuberculous or nontuberculous).\n\n          -  NO acute opportunistic infection.\n\n          -  Life expectancy of more than 6 months.\n\n          -  Consent of parent or guardian if less than legal age of consent.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following symptoms or conditions are excluded:\n\n        ALL PATIENTS -\n\n          -  Unexplained fevers, elevation in alkaline phosphatase, pancytopenia, abnormal liver\n             function tests, or odynophagia for which the diagnoses of MAC and fungal infections\n             have not been excluded.\n\n          -  Serious hypersensitivity reactions to macrolides or rifampin.\n\n          -  Unable to tolerate oral medications. FOR FLUCONAZOLE RANDOMIZATION -\n\n          -  Serious hypersensitivity reaction to fluconazole.\n\n          -  Active fungal infection (cryptococcosis, histoplasmosis, blastomycosis,\n             aspergillosis, Candida esophagitis, thrush, vaginal candidiasis).\n\n          -  Positive baseline urine cryptococcal culture.\n\n        Concurrent Medication:\n\n        Excluded for fluconazole randomization:\n\n          -  Maintenance therapy for deep fungal infections.\n\n          -  Chronic therapy with ketoconazole or fluconazole."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "12 Years"
        }, 
        "enrollment": "720", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002122", 
            "org_study_id": "226A", 
            "secondary_id": "066-174"
        }, 
        "intervention": [
            {
                "intervention_name": "Azithromycin", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Rifabutin", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Fluconazole", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Fluconazole", 
                "Azithromycin", 
                "Rifabutin"
            ]
        }, 
        "keyword": [
            "Rifabutin", 
            "Mycobacterium avium-intracellulare Infection", 
            "Mycoses", 
            "Drug Therapy, Combination", 
            "Fluconazole", 
            "Acquired Immunodeficiency Syndrome", 
            "Azithromycin"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90033"
                    }, 
                    "name": "Los Angeles County - USC Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orange", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92668"
                    }, 
                    "name": "UCI Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92103"
                    }, 
                    "name": "UCSD Treatment Ctr / Dept of Medicine and Pediatrics"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Jose", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "951282699"
                    }, 
                    "name": "Santa Clara Valley Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Torrance", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90509"
                    }, 
                    "name": "Harbor - UCLA Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20007"
                    }, 
                    "name": "Georgetown Univ Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20037"
                    }, 
                    "name": "George Washington Univ Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Worcester", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "01655"
                    }, 
                    "name": "Univ of Massachusetts Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19104"
                    }, 
                    "name": "Univ of Pennsylvania"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75235"
                    }, 
                    "name": "Univ of Texas Southwestern Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77005"
                    }, 
                    "name": "Baylor College of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }, 
                    "name": "Houston Veterans Administration Med Ctr"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 3", 
        "reference": {
            "citation": "Havlir DV, Mccutchan JA, Bozzette SA, Dunne M. A double-blind, randomized study of weekly azithromycin, daily rifabutin, and combination azithromycin and rifabutin for the prevention of Mycobactetum avium complex (MAC) in AIDS patients. Conf Retroviruses Opportunistic Infect. 1996 Jan 28-Feb 1;3rd:90"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002122"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pfizer", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Endpoint Classification: Efficacy Study, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 1996"
    }, 
    "geocoordinates": {
        "Baylor College of Medicine": "29.76 -95.369", 
        "George Washington Univ Med Ctr": "38.895 -77.036", 
        "Georgetown Univ Med Ctr": "38.895 -77.036", 
        "Harbor - UCLA Med Ctr": "33.836 -118.341", 
        "Houston Veterans Administration Med Ctr": "29.76 -95.369", 
        "Los Angeles County - USC Med Ctr": "34.052 -118.244", 
        "Santa Clara Valley Med Ctr": "37.339 -121.895", 
        "UCI Med Ctr": "33.788 -117.853", 
        "UCSD Treatment Ctr / Dept of Medicine and Pediatrics": "32.715 -117.157", 
        "Univ of Massachusetts Med Ctr": "42.263 -71.802", 
        "Univ of Pennsylvania": "39.952 -75.164", 
        "Univ of Texas Southwestern Med Ctr": "32.803 -96.77"
    }
}